Medicine
FDA Approves First in Class Oral Drug for Advanced Multiple Myeloma
The FDA has approved a groundbreaking oral treatment for advanced multiple myeloma, introducing a new class of medicine for patients with the blood cancer.
Safety concerns raised over new Prader Willi syndrome drug
Experts raise concerns about potential safety risks, including patient deaths, associated with a newly approved drug for Prader Willi syndrome by Neurocrine Biosciences.
FDA Rejects Radiopharmaceutical Therapy Over Manufacturing Concerns
The FDA has declined approval for a promising radiopharmaceutical therapy, citing manufacturing concerns, delaying its competition with Novartis' treatment.
China tightens clinical trial rules impacting global research collaboration
China has implemented tighter controls on investigator initiated clinical trials, disrupting international research partnerships and prompting concerns about future collaboration.
Pioneering Researcher Who Linked HPV to Throat Cancer Dies at 61
Dr. Maura Gillison transformed cancer research by proving HPV causes throat cancer, shifting prevention strategies and saving lives.
Radiopharmaceuticals face safety and regulatory hurdles despite cancer promise
Radiopharmaceuticals show promise as cancer treatments but face growing safety concerns and regulatory challenges that could slow progress.
Tenax Therapeutics heart failure drug fails in late stage trial
Tenax Therapeutics' experimental heart failure drug, Levosimendan, failed to meet primary endpoints in a late stage clinical trial, raising concerns about its efficacy.
FDA Approves Replimune Cancer Therapy as Biotech Hubs Shift
The FDA has approved Replimune's oncolytic virus therapy for skin cancer, marking a milestone for the company and signaling broader shifts in the biotech industry's geographic landscape.
Inpatient Prehab Program Aims to Strengthen Heart Transplant Candidates
A novel inpatient prehabilitation program is helping heart transplant candidates regain strength and improve surgical outcomes while waiting for donor hearts.
Inside the Story
Safety concerns raised over new Prader Willi syndrome drug
Experts raise concerns about potential safety risks, including patient deaths, associated with a newly approved drug for Prader Willi syndrome by Neurocrine Biosciences.
FDA Rejects Radiopharmaceutical Therapy Over Manufacturing Concerns
The FDA has declined approval for a promising radiopharmaceutical therapy, citing manufacturing concerns, delaying its competition with Novartis' treatment.
China tightens clinical trial rules impacting global research collaboration
China has implemented tighter controls on investigator initiated clinical trials, disrupting international research partnerships and prompting concerns about future collaboration.
Pioneering Researcher Who Linked HPV to Throat Cancer Dies at 61
Dr. Maura Gillison transformed cancer research by proving HPV causes throat cancer, shifting prevention strategies and saving lives.
Radiopharmaceuticals face safety and regulatory hurdles despite cancer promise
Radiopharmaceuticals show promise as cancer treatments but face growing safety concerns and regulatory challenges that could slow progress.
Tenax Therapeutics heart failure drug fails in late stage trial
Tenax Therapeutics' experimental heart failure drug, Levosimendan, failed to meet primary endpoints in a late stage clinical trial, raising concerns about its efficacy.
FDA Approves Replimune Cancer Therapy as Biotech Hubs Shift
The FDA has approved Replimune's oncolytic virus therapy for skin cancer, marking a milestone for the company and signaling broader shifts in the biotech industry's geographic landscape.
Inpatient Prehab Program Aims to Strengthen Heart Transplant Candidates
A novel inpatient prehabilitation program is helping heart transplant candidates regain strength and improve surgical outcomes while waiting for donor hearts.
